Life Sciences Lifeline: CAR T-Cell Therapy - A New Game-Changing Therapy in Cancer Treatment

CAR T-Cell Therapy, short for Chimeric Antigen Receptor T-Cell Therapy, is an extraordinary and innovative cancer treatment that engineers a patient’s own cells to hunt and attack cancer cells.

With a number of new FDA-approved products on the market, this personalized, next-generation treatment is a powerful tool for treating advanced forms of blood cancer, bringing newfound hope to patients and families while changing the treatment paradigm and traditional approach in cancer care.

In this presentation, you’ll learn about the amazing innovation of CAR T, how it works, and the potential benefits to patients.

Questions? Email Lindsay Hulliberger or call 312-214-5661.